JP2002504318A - 糖結合薬物用輸送体タンパク質 - Google Patents

糖結合薬物用輸送体タンパク質

Info

Publication number
JP2002504318A
JP2002504318A JP2000532429A JP2000532429A JP2002504318A JP 2002504318 A JP2002504318 A JP 2002504318A JP 2000532429 A JP2000532429 A JP 2000532429A JP 2000532429 A JP2000532429 A JP 2000532429A JP 2002504318 A JP2002504318 A JP 2002504318A
Authority
JP
Japan
Prior art keywords
nucleic acid
cells
sugar
transporter
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000532429A
Other languages
English (en)
Japanese (ja)
Inventor
ケプゼル，ヘルマン
ヴィースレル，マンフレット
Original Assignee
ドイチェス クレブスフォルシュンクスツェントルム スチフトゥング デス エッフェントリヒェン レヒツ
ケプゼル，ヘルマン
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ドイチェス クレブスフォルシュンクスツェントルム スチフトゥング デス エッフェントリヒェン レヒツ, ケプゼル，ヘルマン filed Critical ドイチェス クレブスフォルシュンクスツェントルム スチフトゥング デス エッフェントリヒェン レヒツ
Publication of JP2002504318A publication Critical patent/JP2002504318A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/11—Immunoglobulins specific features characterized by their source of isolation or production isolated from eggs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2000532429A 1998-02-18 1999-02-18 糖結合薬物用輸送体タンパク質 Pending JP2002504318A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19806803.4 1998-02-18
DE19806803A DE19806803A1 (de) 1998-02-18 1998-02-18 Transporter für Saccharid-gekoppelte Zytostatika in Tumorzellen
PCT/DE1999/000535 WO1999042477A2 (de) 1998-02-18 1999-02-18 Transporterprotein für saccharid-gekoppelte arzneimittel

Publications (1)

Publication Number Publication Date
JP2002504318A true JP2002504318A (ja) 2002-02-12

Family

ID=7858192

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000532429A Pending JP2002504318A (ja) 1998-02-18 1999-02-18 糖結合薬物用輸送体タンパク質

Country Status (4)

Country Link
EP (1) EP1056857A2 (de)
JP (1) JP2002504318A (de)
DE (1) DE19806803A1 (de)
WO (1) WO1999042477A2 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015514756A (ja) * 2012-04-19 2015-05-21 エライゾン ファーマシューティカルズ， エルエルシー がんのためのグルフォスファミド組み合わせ療法

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6515117B2 (en) * 1999-10-12 2003-02-04 Bristol-Myers Squibb Company C-aryl glucoside SGLT2 inhibitors and method
US20030054453A1 (en) * 2001-04-10 2003-03-20 Millennium Pharmaceuticals, Inc. 68723, sodium/glucose cotransporter family members and uses therefor
US7258971B2 (en) * 2003-01-15 2007-08-21 Bayer Healthcare Ag Methods and compositions for treating urological disorders using carboxypeptidase Z identified as 8263

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015514756A (ja) * 2012-04-19 2015-05-21 エライゾン ファーマシューティカルズ， エルエルシー がんのためのグルフォスファミド組み合わせ療法

Also Published As

Publication number Publication date
EP1056857A2 (de) 2000-12-06
DE19806803A1 (de) 1999-11-25
WO1999042477A3 (de) 2000-03-30
WO1999042477A2 (de) 1999-08-26
WO1999042477A8 (de) 1999-11-04

Similar Documents

Publication Publication Date Title
JP5583308B2 (ja) ２１個のヒト分泌タンパク質
US20050019866A1 (en) 52 Human secreted proteins
US6077948A (en) Mediators of chronic allograft rejection (AIF-1) and DNA encoding them
JP2000333675A (ja) ヒト多形性上皮ムチンコアタンパク質およびそのタンパク質をコードする核酸
JP2003514541A (ja) １８個のヒト分泌タンパク質
JP2003125786A (ja) 可溶型ｒａｇｅタンパク質
JP2003528587A (ja) ２７個のヒト分泌タンパク質
WO2006137597A9 (ja) 新規生理物質ｎｅｓｆａｔｉｎとその関連物質、およびそれらの用途
PL215160B1 (pl) Kompozycja, zastosowanie sondy polinukleotydowej, zastosowanie przeciwciala, przeciwcialo, koniugat, zastosowanie przeciwciala i koniugatu, zestaw do wykrywania ekspresji albo nieprawidlowej ekspresji, sposób diagnozowania nowotworu in vitro okreslania regresji, przebiegu albo poczatku nowotworu
JP2002532092A (ja) プロスタサイクリン刺激因子−２
CA2399045A1 (en) Keratinocyte growth factor-2
EP1586325A1 (de) Galectin 9 enthaltende arzneimittel
JP2002539842A (ja) ４５個のヒト分泌タンパク質
US20070014787A1 (en) 71 human secreted proteins
JP2002542766A (ja) ５０個のヒト分泌タンパク質
JP2003514543A (ja) ２３個のヒト分泌タンパク質
JP2002504318A (ja) 糖結合薬物用輸送体タンパク質
JP4190291B2 (ja) 癌細胞の増殖を調節するのに有用なポリヌクレオチド
JP2002534972A (ja) ３３個のヒト分泌タンパク質
JP2002538811A (ja) ４９個のヒト分泌タンパク質
AU7354700A (en) Human neuropeptide receptor
JP2003520032A (ja) ２４個のヒト分泌タンパク質
JP2002539778A (ja) ４９個のヒト分泌タンパク質
US7314922B1 (en) Ctage gene family
JP2003520031A (ja) ２８個のヒト分泌タンパク質